In today’s episode we talk about how alumni from the German Accelerator Life Sciences program are involved in the tackling of COVID-19. Daniel Mark is the Co-Founder and CEO of Spindiag, a diagnostics company involved in rapid testing for coronavirus infections. Oliver Uecke is the Head of Business Operations at Lipotype, a company providing lipid analysis services. They are certified to analyze samples infected with SARS-CoV-2 and are looking into the role lipidomics can play in coronavirus research. For the non-scientists among us, lipids are a diverse group of small molecules such as triglycerides, cholesterol or fatty acids amongst others!

In our conversation we talk about how exactly their companies are involved in finding solutions for COVID-19, the impact of the whole situation on their companies such as for Spindiag it meant completely shifting their product from rapid testing for multidrug-resistant bacteria to testing for corona viruses and how they both perceive the “gold rush” in their field at the current moment.

Two great guests and a very significant topic! Enjoy the conversation!